Relación precio/ingresos de explotación (P/OP)
desde 2005
Cálculo
Abbott Laboratories, P/OP, tendencias a largo plazocálculo
| P/OP | = | Precio de la acción1, 2, 3 | ÷ | Beneficio operativo por acción1 | Beneficio operativo por acción1 | = | Utilidad operativa1 (en millones) |
÷ | Número de acciones ordinarias en circulación2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 feb 2025 | 34.28 | = | 134.92 | ÷ | 3.94 | 3.94 | = | 6,825 | ÷ | 1,734,323,411 | |
| 16 feb 2024 | 30.54 | = | 114.01 | ÷ | 3.73 | 3.73 | = | 6,478 | ÷ | 1,735,184,289 | |
| 17 feb 2023 | 22.18 | = | 106.74 | ÷ | 4.81 | 4.81 | = | 8,362 | ÷ | 1,737,946,233 | |
| 18 feb 2022 | 24.45 | = | 116.79 | ÷ | 4.78 | 4.78 | = | 8,425 | ÷ | 1,763,482,267 | |
| 19 feb 2021 | 40.69 | = | 123.04 | ÷ | 3.02 | 3.02 | = | 5,357 | ÷ | 1,771,529,358 | |
| 21 feb 2020 | 34.03 | = | 87.45 | ÷ | 2.57 | 2.57 | = | 4,532 | ÷ | 1,763,433,243 | |
| 22 feb 2019 | 36.64 | = | 76.13 | ÷ | 2.08 | 2.08 | = | 3,650 | ÷ | 1,756,470,269 | |
| 16 feb 2018 | 60.88 | = | 60.17 | ÷ | 0.99 | 0.99 | = | 1,726 | ÷ | 1,746,333,892 | |
| 17 feb 2017 | 24.25 | = | 44.69 | ÷ | 1.84 | 1.84 | = | 3,185 | ÷ | 1,727,997,596 | |
| 19 feb 2016 | 19.80 | = | 38.53 | ÷ | 1.95 | 1.95 | = | 2,867 | ÷ | 1,473,241,861 | |
| 27 feb 2015 | 27.50 | = | 47.37 | ÷ | 1.72 | 1.72 | = | 2,599 | ÷ | 1,508,977,828 | |
| 21 feb 2014 | 22.79 | = | 38.82 | ÷ | 1.70 | 1.70 | = | 2,629 | ÷ | 1,543,070,300 | |
| 15 feb 2013 | 6.82 | = | 35.08 | ÷ | 5.15 | 5.15 | = | 8,085 | ÷ | 1,570,677,029 | |
| 21 feb 2012 | 15.35 | = | 56.16 | ÷ | 3.66 | 3.66 | = | 5,752 | ÷ | 1,572,356,859 | |
| 18 feb 2011 | 11.92 | = | 46.88 | ÷ | 3.93 | 3.93 | = | 6,088 | ÷ | 1,547,581,805 | |
| 19 feb 2010 | 13.54 | = | 54.38 | ÷ | 4.02 | 4.02 | = | 6,236 | ÷ | 1,552,643,385 | |
| 20 feb 2009 | 14.66 | = | 54.03 | ÷ | 3.68 | 3.68 | = | 5,694 | ÷ | 1,545,382,675 | |
| 19 feb 2008 | 18.76 | = | 55.57 | ÷ | 2.96 | 2.96 | = | 4,579 | ÷ | 1,545,737,903 | |
| 23 feb 2007 | 40.49 | = | 53.59 | ÷ | 1.32 | 1.32 | = | 2,042 | ÷ | 1,543,073,501 | |
| 22 feb 2006 | 15.48 | = | 43.90 | ÷ | 2.84 | 2.84 | = | 4,362 | ÷ | 1,538,625,812 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$
2 Datos ajustados por divisiones y dividendos de acciones.
3 Precio de cierre a la fecha de presentación del informe anual de Abbott Laboratories
Comparación con la competencia
Abbott Laboratories, P/OP, tendencias a largo plazo, comparación con los competidores
| Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|
| 21 feb 2025 | 34.28 | 9.36 | 86.83 | 19.98 | 13.27 |
| 16 feb 2024 | 30.54 | 6.96 | 75.42 | 21.20 | 14.20 |
| 17 feb 2023 | 22.18 | 14.75 | 54.49 | 20.48 | 15.89 |
| 18 feb 2022 | 24.45 | 10.43 | 56.11 | 37.44 | 18.77 |
| 19 feb 2021 | 40.69 | 6.65 | 88.37 | 26.29 | 14.12 |
| 21 feb 2020 | 34.03 | 7.83 | 48.89 | 21.26 | 14.40 |
| 22 feb 2019 | 36.64 | 18.65 | 49.87 | 17.64 | 14.58 |
| 16 feb 2018 | 60.88 | 7.44 | 44.40 | 22.64 | 14.42 |
| 17 feb 2017 | 24.25 | 7.65 | 28.93 | 22.18 | 11.79 |
| 19 feb 2016 | 19.80 | 10.49 | 27.25 | 28.81 | 9.59 |
| 27 feb 2015 | 27.50 | 13.00 | 34.42 | 16.68 | 10.12 |
| 21 feb 2014 | 22.79 | 10.12 | 17.96 | 11.80 | 7.22 |
| 15 feb 2013 | 6.82 | 8.71 | 26.21 | — | 6.32 |
| 21 feb 2012 | 15.35 | 9.11 | 27.83 | — | 6.55 |
| 18 feb 2011 | 11.92 | 7.34 | 23.28 | — | 5.90 |
| 19 feb 2010 | 13.54 | 7.29 | 33.47 | — | 5.95 |
| 20 feb 2009 | 14.66 | 6.20 | 14.45 | — | 6.59 |
| 19 feb 2008 | 18.76 | 12.09 | 55.84 | — | 7.62 |
| 23 feb 2007 | 40.49 | 10.68 | 38.98 | — | 10.47 |
| 22 feb 2006 | 15.48 | 12.37 | 50.21 | — | 14.87 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).